跳至主要内容
临床试验/CTRI/2026/02/104692
CTRI/2026/02/104692尚未招募2 期

Comparative Clinical Study To Evaluate The Efficacy Of Shothaghna Lepa And Shothaghna Transdermal Patch In The Management Of Sandhigata Vata (Sama Avastha)- A Randomized Controlled Trial

Dr Deependra Karnawat1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年3月9日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
30
试验地点
1

研究概览

简要总结

This study is a randomized, open-label, two-arm comparative clinical trial to evaluate the efficacy of classical Shothaghna Lepa versus Shothaghna Transdermal Patch in the management of Sandhigatavata. A total of 30 patients (15 in each group) diagnosed with Sandhigatavata will be recruited from OPD/IPD and randomly allocated to receive either daily application of classical Shothaghna Lepa or a standardized Shothaghna transdermal patch for 7 days, with follow-up on Day 14. The primary outcome will be reduction in joint swelling (Sandhishotha), while secondary outcomes include improvement in pain, stiffness, patient compliance, and safety. The study aims to compare the clinical effectiveness and usability of a traditional Ayurvedic Lepa with a patient-friendly transdermal patch formulation to provide a more convenient and effective external therapy for inflammatory joint conditions.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patient fulfilling the signs and symptoms of samsandhigatvata Vata Patient of all socio-economic group.
  • Patient who is willing to give written consent.

排除标准

  • Patient having known allergic reactions to the components of the Shothaghna Lepa.
  • Patient having other joint diseases like Psoriatic Arthritis, Gout Arthritis and Rheumatoid Arthritis.
  • Patient with Pregnancy and lactating women.

研究者

发起方
Dr Deependra Karnawat
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Deependra Karnawat

Parul Institute of Ayurved and Research

研究点 (1)

Loading locations...

相似试验

Efficacy of Shothaghna Lepa and Transdermal Patch in... | 临床试验